공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 자동 무효화 시린지 시장 : 적응증별, 사이즈별, 최종사용자별, 용도별 예측(-2025년) - COVID-19의 누적 영향

Auto-disable Syringes Market Research Report by Indication, by Size, by End-User, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1001141
페이지 정보 영문 197 Pages
가격
US $ 3,949 ₩ 4,523,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,669,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,105,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,396,000 PDF (Enterprise License) + Excel


세계의 자동 무효화 시린지 시장 : 적응증별, 사이즈별, 최종사용자별, 용도별 예측(-2025년) - COVID-19의 누적 영향 Auto-disable Syringes Market Research Report by Indication, by Size, by End-User, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 197 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 자동 무효화 시린지 시장은 2020년 169억 2,156만 달러에서 2025년 말까지 278억 9,367만 달러로 성장할 것으로 예상됩니다.

COVID-19는 거의 모든 업계에 영향을 미친 미증유의 세계 공중위생상 긴급사태이기 때문에 예측기간 중 업계의 성장에 장기적인 영향을 미칠 것으로 예측됩니다. 기저에 있는 COVID-19의 문제와 향후 방향을 확실히 다루기 위해 조사 범위를 확대하고, 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재라우팅, 현재 시장 동향 및 정부의 중요한 개입 등을 고려하면서, COVID-19의 영향에 대해 분석하고 있습니다.

세계의 자동 무효화 시린지(Auto-disable Syringes) 시장에 대해 조사했으며, 시장 기회와 과제, 성장 촉진요인 및 억제요인, COVID-19의 누적 영향, 적응증·사이즈·최종사용자·용도·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 커버리지
  • 조사 기간
  • 통화와 가격
  • 언어
  • 제한
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 설계
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 갱신
  • 조사 실행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 실행 : 조사 실시
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 주요 요약

  • 시장 전망
  • 최종사용자별 시장 전망
  • 적응증별 시장 전망
  • 용도별 시장 전망
  • 사이즈별 시장 전망
  • 지역별 시장 전망
  • 경쟁사 전망

제4장 시장 개요

  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porter's Five Forces 분석

제6장 적응증별 시장

  • 감염증
  • 염증성/자가면역질환
  • 백신

제7장 사이즈별 시장

  • 0.05ml
  • 0.1ml
  • 0.3ml
  • 0.5ml
  • 1ml
  • 10ml
  • 3ml
  • 5ml

제8장 최종사용자별 시장

  • 외래 수술 센터
  • 진단 연구소
  • 병원

제9장 용도별 시장

  • 채혈
  • 약물전달
  • 예방접종

제10장 아메리카 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제11장 아시아태평양 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제12장 유럽, 중동 및 아프리카 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제13장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 인수합병
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금 조달
    • 평가, 인지, 확대

제14장 기업 개요

  • AccuPoint
  • AdvaCare Pharma
  • AlShifa Medical Products Co.
  • AlShifa Medical Syringe Manufacturing Company
  • Arab Medical Equipment Company
  • Avapezeshk
  • Becton Dickinson & Company(BD)
  • Destroject
  • Duopross Meditech Corp.
  • Hamilton Syringes(Sigma-Aldrich)
  • Hindustan Syringes and Medical Devices
  • Hunan Pingan Medical Device Technology Co.,Ltd.
  • Injecto A/S
  • Iscon Surgicals Ltd
  • JMI Group
  • L.O.M. Medical International
  • Medis Medical
  • PT Oneject
  • Retractable Technologies, Inc.
  • Sanavita Pharmaceuticals Gmbh
  • Shandong Zhushi Pharmaceutical Group Co.,Ltd
  • SRS Meditech Limited
  • Terumo Medical Corporation
  • Vogt Medical
  • Zibo Eastmed Healthcare Products Co., Ltd.

제15장 부록

  • 논의 가이드
  • 라이선스와 가격
KSM 21.05.06

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2026
  • FIGURE 12. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2020 VS 2026 (%)
  • FIGURE 19. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2026
  • FIGURE 21. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.05 ML, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.05 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.1 ML, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.1 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.3 ML, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.3 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.5 ML, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.5 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 1 ML, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 1 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 10 ML, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 10 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 3 ML, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 3 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 5 ML, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 5 ML, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 38. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2026
  • FIGURE 40. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD BILLION)
  • FIGURE 41. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 42. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2026 (USD BILLION)
  • FIGURE 43. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 44. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
  • FIGURE 45. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 46. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 47. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 49. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, 2018-2026 (USD BILLION)
  • FIGURE 50. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, 2018-2026 (USD BILLION)
  • FIGURE 52. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 53. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2026 (USD BILLION)
  • FIGURE 54. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 55. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. CALIFORNIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. FLORIDA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. ILLINOIS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. NEW YORK AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. OHIO AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. PENNSYLVANIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. TEXAS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 71. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 72. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 73. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 82. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 83. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 84. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 86. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 87. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 88. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 89. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 90. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 91. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 92. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 93. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 94. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 95. GLOBAL AUTO-DISABLE SYRINGES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 96. GLOBAL AUTO-DISABLE SYRINGES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 97. GLOBAL AUTO-DISABLE SYRINGES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 98. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTO-DISABLE SYRINGES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL AUTO-DISABLE SYRINGES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.05 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.1 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.3 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 0.5 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 1 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 10 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 3 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY 5 ML, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. CALIFORNIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. CALIFORNIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. CALIFORNIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. CALIFORNIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. FLORIDA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. FLORIDA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. FLORIDA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. FLORIDA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ILLINOIS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ILLINOIS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. ILLINOIS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. ILLINOIS AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. NEW YORK AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. NEW YORK AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. NEW YORK AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. NEW YORK AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. OHIO AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. OHIO AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. OHIO AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. OHIO AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. PENNSYLVANIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. PENNSYLVANIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. PENNSYLVANIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. PENNSYLVANIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. TEXAS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. TEXAS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. TEXAS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. TEXAS AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 125. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 127. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 128. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 129. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 130. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 131. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 132. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 133. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 134. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 135. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 136. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 137. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 138. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 139. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 140. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 141. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 142. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 143. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 144. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 145. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 146. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 147. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 148. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 149. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 150. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 151. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 152. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 153. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 154. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 155. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 156. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 157. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 158. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 159. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 160. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 161. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 162. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 163. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY SIZE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 164. GLOBAL AUTO-DISABLE SYRINGES MARKET: SCORES
  • TABLE 165. GLOBAL AUTO-DISABLE SYRINGES MARKET: BUSINESS STRATEGY
  • TABLE 166. GLOBAL AUTO-DISABLE SYRINGES MARKET: PRODUCT SATISFACTION
  • TABLE 167. GLOBAL AUTO-DISABLE SYRINGES MARKET: RANKING
  • TABLE 168. GLOBAL AUTO-DISABLE SYRINGES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 169. GLOBAL AUTO-DISABLE SYRINGES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 170. GLOBAL AUTO-DISABLE SYRINGES MARKET: MERGER & ACQUISITION
  • TABLE 171. GLOBAL AUTO-DISABLE SYRINGES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 172. GLOBAL AUTO-DISABLE SYRINGES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 173. GLOBAL AUTO-DISABLE SYRINGES MARKET: INVESTMENT & FUNDING
  • TABLE 174. GLOBAL AUTO-DISABLE SYRINGES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 175. GLOBAL AUTO-DISABLE SYRINGES MARKET: LICENSE & PRICING
  • TABLE 176. GLOBAL AUTO-DISABLE SYRINGES MARKET: CONTACT DETAILS

The Global Auto-disable Syringes Market size was estimated at USD 16.92 Billion in 2020 and expected to reach USD 18.78 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 11.35% to reach USD 32.25 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Auto-disable Syringes to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Indication, the Auto-disable Syringes Market was studied across Infectious Diseases, Inflammatory/Auto-Immune Diseases, and Vaccines.

Based on Size, the Auto-disable Syringes Market was studied across 0.05 ml, 0.1 ml, 0.3 ml, 0.5 ml, 1 ml, 10 ml, 3 ml, and 5 ml.

Based on End-User, the Auto-disable Syringes Market was studied across Ambulatory Surgical Centers, Diagnostic Laboratories, and Hospitals.

Based on Application, the Auto-disable Syringes Market was studied across Blood Collection, Drug Delivery, and Vaccination.

Based on Geography, the Auto-disable Syringes Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Auto-disable Syringes Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Auto-disable Syringes Market, including AccuPoint, AdvaCare Pharma, AlShifa Medical Products Co., AlShifa Medical Syringe Manufacturing Company, Arab Medical Equipment Company, Avapezeshk, Becton Dickinson & Company (BD), Destroject, Duopross Meditech Corp., Hamilton Syringes (Sigma-Aldrich), Hindustan Syringes and Medical Devices, Hunan Pingan Medical Device Technology Co.,Ltd., Injecto A/S, Iscon Surgicals Ltd, JMI Group, L.O.M. Medical International, Medis Medical, PT Oneject, Retractable Technologies, Inc., Sanavita Pharmaceuticals Gmbh, Shandong Zhushi Pharmaceutical Group Co.,Ltd, SRS Meditech Limited, Terumo Medical Corporation, Vogt Medical, and Zibo Eastmed Healthcare Products Co., Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Auto-disable Syringes Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Auto-disable Syringes Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Auto-disable Syringes Market?
  • 4. What is the competitive strategic window for opportunities in the Global Auto-disable Syringes Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Auto-disable Syringes Market?
  • 6. What is the market share of the leading vendors in the Global Auto-disable Syringes Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Auto-disable Syringes Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-User Outlook
  • 3.4. Indication Outlook
  • 3.5. Application Outlook
  • 3.6. Size Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of needle stick injuries and cross infection
      • 5.1.1.2. Growing R&D activities in the field in the recent years
      • 5.1.1.3. Stringent regulations by government for safety
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of procurement and raw material
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing scope in mass application campaign
      • 5.1.3.2. Vendor focus towards advancement and sustainability
    • 5.1.4. Challenges
      • 5.1.4.1. Supply challenges for AD syringes in private hospitals
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Auto-disable Syringes Market, by Indication

  • 6.1. Introduction
  • 6.2. Infectious Diseases
  • 6.3. Inflammatory/Auto-Immune Diseases
  • 6.4. Vaccines

7. Auto-disable Syringes Market, by Size

  • 7.1. Introduction
  • 7.2. 0.05 ml
  • 7.3. 0.1 ml
  • 7.4. 0.3 ml
  • 7.5. 0.5 ml
  • 7.6. 1 ml
  • 7.7. 10 ml
  • 7.8. 3 ml
  • 7.9. 5 ml

8. Auto-disable Syringes Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals

9. Auto-disable Syringes Market, by Application

  • 9.1. Introduction
  • 9.2. Blood Collection
  • 9.3. Drug Delivery
  • 9.4. Vaccination

10. Americas Auto-disable Syringes Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Auto-disable Syringes Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Auto-disable Syringes Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. AccuPoint
  • 14.2. AdvaCare Pharma
  • 14.3. AlShifa Medical Products Co.
  • 14.4. AlShifa Medical Syringe Manufacturing Company
  • 14.5. Arab Medical Equipment Company
  • 14.6. Avapezeshk
  • 14.7. Becton Dickinson & Company (BD)
  • 14.8. Destroject
  • 14.9. Duopross Meditech Corp.
  • 14.10. Hamilton Syringes (Sigma-Aldrich)
  • 14.11. Hindustan Syringes and Medical Devices
  • 14.12. Hunan Pingan Medical Device Technology Co.,Ltd.
  • 14.13. Injecto A/S
  • 14.14. Iscon Surgicals Ltd
  • 14.15. JMI Group
  • 14.16. L.O.M. Medical International
  • 14.17. Medis Medical
  • 14.18. PT Oneject
  • 14.19. Retractable Technologies, Inc.
  • 14.20. Sanavita Pharmaceuticals Gmbh
  • 14.21. Shandong Zhushi Pharmaceutical Group Co.,Ltd
  • 14.22. SRS Meditech Limited
  • 14.23. Terumo Medical Corporation
  • 14.24. Vogt Medical
  • 14.25. Zibo Eastmed Healthcare Products Co., Ltd.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details
Back to Top
전화 문의
F A Q